Desmopressin Improves Platelet Activity in Acute Intracerebral Hemorrhage [Brief Reports]

Conclusions— Intravenous desmopressin was well tolerated and improved platelet activity after acute intracerebral hemorrhage. Larger studies are needed to determine its potential effects on reducing hematoma growth versus platelet transfusion or placebo. Clinical Trial Registration— URL: http://www.clinicaltrials.gov. Unique identifier: NCT00961532.

http://stroke.ahajournals.org/cgi/content/short/45/8/2451?rss=1

Source: Stroke - July 28, 2014 Category: Neurology Authors: Naidech, A. M., Maas, M. B., Levasseur-Franklin, K. E., Liotta, E. M., Guth, J. C., Berman, M., Rosenow, J. M., Lindholm, P. F., Bendok, B. R., Prabhakaran, S., Bernstein, R. A., Kwaan, H. C. Tags: Intracerebral Hemorrhage, Other Stroke Treatment - Medical, Platelets Brief Reports Source Type: research